Company / Assets per Share
Krystal Biotech, Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$46.32
FY2025
5-year range
$21.91 / $46.32
FY2021-FY2025
Trend
+23.9%
vs FY2024
Sector context
#25 of 210
Health Care
What the data says
Krystal Biotech, Inc.'s assets per share of $46.32 is higher than 88% of companies in the Health Care sector (FY2025). Assets per Share has increased for 3 consecutive years, from $21.91 in FY2022 to $46.32 in FY2025.
Based on SEC 10-K filings.
46.32 in FY2025 with a 5-year CAGR of +22.9%. Top quartile in the Health Care sector.
Improved from $31.76 to $46.32 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +28.4%
- 5-Year CAGR
- +22.9%
- 10-Year CAGR
- -
Sector benchmark
-86.9% below sector average
Key checks
Key Insights
- Krystal Biotech, Inc.'s assets per share has grown for 3 consecutive years.
- In FY2025, assets per share increased 23.9% year-over-year.
- Ranks #25 out of 210 companies in the Health Care sector.
- Lowest assets per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 5.66 (safe zone, above 2.9 threshold)
- Strong profit margin: 30.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $46.32 | +23.9% |
| FY2024 | $37.39 | +17.7% |
| FY2023 | $31.76 | +45.0% |
| FY2022 | $21.91 | -22.4% |
| FY2021 | $28.22 | +70.5% |
| FY2020 | $16.55 | +25.9% |
| FY2019 | $13.15 | +26.8% |
| FY2018 | $10.36 | +10.9% |
| FY2017 | $9.35 | +276.0% |
| FY2016 | $2.49 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026